Skip to content
Venture BuildingArticlePart 01 in Common Product Issues That Prevent Product-Market Fit

Common Product Issues That Prevent Product-Market Fit (Part 1)

Six of the most common product issues we found preventing early-stage startups from reaching product-market fit, with the symptoms, evidence, and diagnostic questions for each.

By
Sylvester Mobley
Zero Vector
Published
August 6, 2026
Revised
Not revised
Reading
22 min read
Topics
  • Product-market fit
  • Validation
  • Product
  • Discovery
  • Venture Building
Insight intelligenceVenture BuildingArticleSeriesCommon Product Issues That Prevent Product-Market Fit
22 min read · Published August 6, 2026

Throughout my time investing in early-stage startups, I found myself watching founders run into a common set of product issues.

Then, as the CEO of a venture studio, I watched our team work to overcome many of the same challenges. After years of watching the issues play out over and over in different startups and in different contexts, I felt like I was seeing patterns strong enough to formally invest our time into researching and understanding what was happening.

We then set out to research, catalog, and validate in the real world the common product issues early-stage startups face. We had a specific focus on the common product issues that prevent early-stage startups from reaching product-market fit.

We wanted to publish the list of issues that we identified in the hopes that founders might find it helpful. Due to the size of the list, I decided to turn it into a series instead of publishing it all at once. I also decided not to publish the list in order, instead publishing it based on the issues that, in my biased opinion, are most important to early-stage startups.

1. The Problem Wedge and Problem Statement is Unclear

Pre-seed and seed startups repeatedly struggle to define the exact customer problem and first wedge when they start from a broad idea, technology, category, or founder insight because the urgent use case has not been isolated, forcing them to build, pitch, and validate around vague assumptions, which leads to noisy discovery, unstable roadmap decisions, and weak product-market fit progress.

Definition · Plain-language definition
The startup cannot clearly answer who has the problem, when it happens, what triggers it, why it matters, what they do now, and what is wrong with what they do now.

Why This Matters

Vague problem framing infects everything else: ICP, discovery, MVP scope, roadmap, pricing, onboarding, and how product-market fit gets interpreted. It recurs because founders often begin with insight, technology, or ambition rather than a tightly observed problem. Founders miss it because their idea can be directionally right while the first wedge is still wrong. It appears most often at idea, pre-MVP, prototype, and pre-seed stages, but it can persist into seed. It is common among technical founders, domain-expert founders, and first-time founders.

Root Causes

  • The founder starts from a solution or trend.
  • The customer pain is broad but not specific.
  • The current workaround is not mapped.
  • The trigger event is missing.
  • The ICP is too broad.
  • The product is described as a platform before proving a wedge.
  • The customer language about the problem is not repeated across interviews.

Observable Symptoms

  • Founder behavior: the broad problem holds directionally, but the specific problem statement changes across conversations.
  • Product roadmap: the roadmap includes many unrelated use cases.
  • Customer conversations: customers agree abstractly but describe different pains.
  • Sales calls: prospects struggle to explain urgency.
  • User behavior: early users use the product for different reasons.
  • Analytics: there is no clear activation behavior that maps to value.
  • Engineering work: MVP scope expands.
  • Investor updates: the market narrative is clearer than the customer proof.
  • Team discussions: “What are we really solving?” becomes a repeated conversation.

Common Founder Language

  • “This is a huge problem.”
  • “Every company has this issue.”
  • “We are building the platform for X.”
  • “There are many use cases.”
  • “We are still figuring out the wedge.”

Diagnosis

Founders often think they need better messaging, more features, a clearer vertical, more interviews, or a stronger deck.

Consequences

  • Product direction remains unstable.
  • Customer learning is noisy.
  • UX cannot optimize for a clear job.
  • Retention is hard to interpret.
  • Sales lacks direction.
  • Engineering overbuilds or thrashes.
  • Runway is spent exploring too many directions.
  • Fundraising positioning weakens when investors ask what has been proven.
Evidence test
Confirms the issueDisconfirms the issue
QualitativeInconsistent customer language, unclear workaround, no trigger event, and a broad use-case spread.Customers in a specific segment repeatedly describe the same painful problem, current workaround, trigger, and reason to act.
QuantitativeLow conversion across broad audiences, inconsistent activation behavior, high churn, and weak retention by use case.Product usage and sales patterns begin to cluster around a single wedge.

Diagnostic Questions

  1. Who exactly has the problem?
  2. What are they trying to do when it appears?
  3. What breaks or becomes painful?
  4. What do they do now?
  5. What does the workaround cost?
  6. Why solve it now?
  7. Which customers feel it most intensely?
  8. What is the smallest product wedge that addresses it?
  9. What use cases are you intentionally excluding?
  10. What customer evidence drove this problem definition?
Figure 1.1
Product metricsActivation by use case, usage depth, retention by segment.
Customer artifactsProblem statements, customer interviews, current-workaround maps.
Sales artifactsDemo notes, lost-deal reasons, buyer language.
Research artifactsInterview synthesis and assumption maps.
Product artifactsRoadmap and MVP scope.
Engineering artifactsFeature churn caused by problem ambiguity.
Metrics and artifacts to inspect
Severity

Mild

Problem is directionally clear but needs a sharper trigger and customer definition.

Moderate

Problem varies across segments and conversations.

Severe

Product and sales are aimed at multiple inconsistent problems.

Fatal

No repeated painful problem can be identified.

Figure 1.2
Pre-seedAmbiguity is common but must be reduced before major build.
SeedPersistent ambiguity is a major product-market fit risk.
Pre-MVPPrototype tests may test a solution without a problem.
Post-MVPUsage patterns are inconsistent.
First revenueCustomers pay for different reasons.
False product-market fitTraction hides the lack of a repeatable problem.
Stage-specific version

Adjacent Problems

  • The ICP is too broad.
  • An urgent trigger is missing.
  • The workaround is misunderstood.
  • There is category confusion.

2. Willingness to Pay Not Validated

Pre-seed and seed startups repeatedly struggle to prove whether the right buyer will pay when they validate interest, usage, or feedback without asking for money or a budget commitment, forcing them to serve non-paying demand and leading to weak monetization evidence and incomplete product-market fit validation.

Definition · Plain-language definition
The product may be useful, but the startup has not proven that the right buyer values it enough to pay.

Why This Matters

Payment is one of the strongest behavioral commitment signals. This issue recurs because founders either avoid pricing conversations or early prospects avoid committing to paying. It damages product-market fit because unpaid usage can look like demand without proving economic value. Founders often miss it because customers can genuinely like a product they will not pay for. It appears from pre-product-market fit through seed, especially during free betas, pilots, prosumer usage, AI experimentation, and early B2B discovery, and it shows up across B2B SaaS, SMB software, consumer subscription, prosumer tools, developer tools, marketplaces, and AI products.

Root Causes

  • The price is deferred.
  • The buyer and user are confused.
  • The budget owner is unknown.
  • The value outcome is unclear.
  • Free users are not the economic buyers.
  • The founder fears rejection from buyers.
  • The product is a nice-to-have rather than a solution to a painful, urgent problem.
  • The pilot terms do not include conversion.

Observable Symptoms

  • Founder behavior: avoids pricing conversations.
  • Product roadmap: built for free users.
  • Customer conversations: “Would you pay?” answers are accepted at face value.
  • Sales calls: budget is unclear.
  • User behavior: free usage does not convert.
  • Analytics: high free engagement, low paid conversion.
  • Engineering work: supports non-paying customer requests.
  • Investor updates: usage is shown without revenue quality.
  • Team discussions: monetization is pushed later.

Common Founder Language

  • “We will monetize later.”
  • “They said they would pay.”
  • “We need more users before charging.”
  • “Pricing is premature.”
  • “The pilot should be free so we can learn.”

Diagnosis

Founders often think they need more features, more users, better onboarding, lower prices, or more time before charging.

Consequences

  • The product direction overfits for free users.
  • Customer learning misses the budget reality.
  • UX may optimize engagement rather than value.
  • Retention may not translate to revenue.
  • Sales lacks price discipline.
  • Engineering serves low-quality demand.
  • Runway is spent without monetization proof.
  • Fundraising readiness weakens if usage lacks commercial conversion.
Evidence test
Confirms the issueDisconfirms the issue
QualitativeBuyers avoid budget discussion, users like the product but cannot pay, and there is no clear budget owner.Customers allocate budget, choose the product over a paid substitute, and name the value that justifies the price.
QuantitativeLow free-to-paid conversion, few paid pilots, heavy discounting, no repeat purchase, and weak paid retention.Customers pay, renew, expand, prepay, and convert from free to paid at a stable rate.

Diagnostic Questions

  1. Who pays?
  2. What budget does the money come from?
  3. What price has been tested?
  4. What happened when you asked for money?
  5. Are users and buyers the same?
  6. What value justifies payment?
  7. What paid alternative exists?
  8. What percentage of free users convert?
  9. What would make the buyer renew?
  10. Are pilots tied to paid conversion?
Figure 2.1
Product metricsFree-to-paid conversion, paid retention, usage by paid versus free.
Customer artifactsBudget owner notes, procurement notes.
Sales artifactsQuotes, contracts, pilot terms, discounting.
Research artifactsPricing interviews, willingness-to-pay tests.
Product artifactsPackaging and value metric definitions.
Engineering artifactsWork driven by free versus paid customers.
Metrics and artifacts to inspect
Severity

Mild

Pricing is early but planned.

Moderate

Product decisions rely on free users.

Severe

Usage is strong, but payment is unproven.

Fatal

The startup cannot convert interest into sustainable revenue.

Figure 2.2
Pre-seedFounders delay asking for money.
Pre-MVPPricing is not being tested through commitments.
Post-MVPFree usage may hide weak demand.
First revenuePayment from one customer may not prove repeatability.
False product-market fitUsage is mistaken for economic demand.
Stage-specific version

Adjacent Problems

  • Stated interest is mistaken for commitment.
  • Pricing is misaligned to value.
  • Stakeholder-role confusion.
  • The free pilot trap.
  • False product-market fit.

3. Riskiest Assumption Not Identified

Pre-seed and seed startups repeatedly struggle to identify the assumption most likely to invalidate the company when many things are uncertain because they test what is easy, exciting, or visible, forcing them to spend time on low-leverage validation, which leads to slow learning and unresolved product-market fit risk.

Definition · Plain-language definition
The team does not know which assumption, if wrong, would make everything else irrelevant.

Why This Matters

Early-stage startups are uncertainty-reduction systems. If the wrong assumption is tested first, the company can look busy while existential risk remains untouched. It recurs because easy tests create faster positive feedback, and founders miss it because activity feels like learning. It appears at idea, pre-MVP, prototype, MVP live, pre-seed, seed, and pre-product-market fit stages, and across nearly all startup types.

Root Causes

  • No assumption map exists.
  • Founder intuition drives test selection.
  • The team avoids hard tests.
  • MVP scope is not tied to risk.
  • Experiments test preference rather than behavior.
  • Fundraising pressure rewards visible activity.
  • The product has multiple unresolved risks.

Observable Symptoms

  • Founder behavior: cannot name the riskiest assumption.
  • Product roadmap: builds features unrelated to core risk.
  • Customer conversations: asks broad validation questions.
  • Sales calls: unresolved buyer, urgency, or budget questions persist.
  • User behavior: usage tests do not address retention or value.
  • Analytics: tracks easy metrics.
  • Engineering work: builds low-risk capabilities.
  • Investor updates: lists experiments without saying what they proved.
  • Team discussions: many tests, little clarity.

Common Founder Language

  • “We are testing a lot.”
  • “We need the MVP to learn.”
  • “There are many unknowns.”
  • “The early signals are promising.”
  • “We are validating step by step.”

Diagnosis

Founders often think they need more data, more experiments, more interviews, more users, or a more complete MVP.

Consequences

  • Product direction advances without reducing existential uncertainty.
  • Customer learning becomes scattered.
  • UX tests may be irrelevant.
  • Retention risks appear late.
  • Sales learns hard truths too late.
  • Engineering builds low-leverage work.
  • Runway burns without risk reduction.
  • Fundraising ability weakens because the biggest risks remain open.
Evidence test
Confirms the issueDisconfirms the issue
QualitativeNo assumption map, no risk ranking, and unclear test rationale.The team can name, rank, and test key assumptions, and each experiment maps to a decision.
QuantitativeExperiments produce positive minor metrics while activation, retention, payment, or adoption remains unresolved.Results change product scope, ICP, pricing, or strategy in measurable ways.

Diagnostic Questions

  1. What assumption could kill the company?
  2. Why is that the riskiest assumption?
  3. What test is currently addressing it?
  4. What result would reduce the risk?
  5. What result would invalidate the direction?
  6. What easy tests are you over-running?
  7. What risk remains untested?
  8. What decision will the next test unlock?
  9. What could be tested before building?
  10. What are you afraid to learn?
Figure 3.1
Product metricsMetrics tied to assumptions, not just activity.
Customer artifactsAssumption-specific interview notes.
Sales artifactsBuyer, budget, urgency, and objection evidence.
Research artifactsAssumption map and experiment backlog.
Product artifactsMVP feature-to-risk map.
Engineering artifactsBuild work tied to assumptions.
Metrics and artifacts to inspect
Severity

Mild

Assumptions are implicit but can be explained.

Moderate

Some tests address secondary risks.

Severe

Major work proceeds while existential risks remain untested.

Fatal

The company validates low-risk questions until runway is gone.

Figure 3.2
Pre-seedThe riskiest assumption often concerns problem urgency, ICP, or buyer.
SeedIt often concerns retention, repeatability, sales motion, or willingness to pay.
Pre-MVPTests may target solution appeal before problem risk.
Post-MVPTests may ignore retained value.
First revenueTests may ignore repeatability.
False product-market fitThe company stops testing because it believes risk is gone.
Stage-specific version

Adjacent Problems

  • Experiments lack decision criteria.
  • You are building before learning.
  • There is low-quality discovery.
  • Pivot criteria are unclear.
  • Stated-interest signals are mistaken for commitment.

4. Experiments, Pilots, and Tests Lack Decision Criteria

Pre-seed and seed startups repeatedly struggle to learn from experiments and pilots when they do not define success, failure, ambiguity, commitment thresholds, or next decisions in advance, forcing them to extend inconclusive tests, which leads to ambiguous learning, wasted runway, and optimistic interpretation.

Definition · Plain-language definition
The startup runs tests, but the tests do not reduce uncertainty or force a decision.

Why This Matters

Ambiguous tests create activity without learning. It recurs because founders want momentum and often fear defining failure. It damages product-market fit because pilots, prototypes, pricing tests, and MVP launches can continue without proving or disproving anything, and founders miss it because any feedback feels useful. It appears in pre-MVP, prototype, MVP live, first pilots, first users, first paying customers, pre-seed, seed, and pre-product-market fit stages, and is common in B2B SaaS, enterprise, AI pilots, developer tools, SMB software, marketplaces, and prosumer tests.

Root Causes

  • The riskiest assumption is unclear.
  • Success and failure thresholds are not defined.
  • Free pilots avoid purchase pressure.
  • Metrics are chosen after the test.
  • Founders prefer optionality.
  • The customer has not agreed to conversion criteria.

Observable Symptoms

  • Founder behavior: says “the signal is promising” without a decision.
  • Product roadmap: continues after ambiguous evidence.
  • Customer conversations: pilots lack clear outcomes.
  • Sales calls: conversion is deferred.
  • User behavior: usage is low, but the pilot continues.
  • Analytics: there is no success threshold.
  • Engineering work: features are added to rescue weak tests.
  • Investor updates: pilots are counted as traction.
  • Team discussions: interpretation happens after results.

Common Founder Language

  • “The pilot is going well.”
  • “We need more data.”
  • “The test was directionally positive.”
  • “They just need more time.”
  • “We are still learning.”

Diagnosis

Founders often think they need a longer pilot, more users, another feature, better onboarding, more customer success, or more data.

Consequences

  • Product direction remains ambiguous.
  • Customer learning is weak.
  • UX fixes may chase unclear outcomes.
  • Retention is not tested properly.
  • Non-decision pilots inflate the sales pipeline.
  • Engineering builds rescue features.
  • Runway is spent extending inconclusive tests.
  • Fundraising ability becomes fragile if pilots do not convert.
Evidence test
Confirms the issueDisconfirms the issue
QualitativeNo written pilot goals, no buyer commitment, and no success criteria.Tests have predefined assumptions, thresholds, timelines, decision owners, and next actions.
QuantitativeLong pilot cycles, low usage, low conversion, repeated extensions, and weak post-test decisions.Results trigger specific build, pivot, price, segment, or kill decisions.

Diagnostic Questions

  1. What assumption is the test addressing?
  2. What result counts as success?
  3. What result counts as failure?
  4. What result is ambiguous?
  5. What happens after success?
  6. What happens after failure?
  7. Who owns the customer-side decision?
  8. What is the time box?
  9. What commitment did the customer make?
  10. Was paid conversion discussed upfront?
Figure 4.1
Product metricsActivation, usage threshold, retention during the pilot.
Customer artifactsPilot agreement, success criteria, stakeholder commitments.
Sales artifactsPilot-to-paid conversion and CRM stage history.
Research artifactsExperiment plans and hypothesis documents.
Product artifactsMVP launch criteria.
Engineering artifactsFeatures added during test extensions.
Metrics and artifacts to inspect
Severity

Mild

Criteria are informal but clear.

Moderate

Some tests lack thresholds.

Severe

Major pilots or MVP launches are inconclusive.

Fatal

The company spends months in ambiguous pilots without commitment or learning.

Figure 4.2
Pre-seedExperiments are run without learning thresholds.
SeedPilots and pricing tests lack conversion criteria.
Pre-MVPPrototypes collect opinions, not decisions.
Post-MVPLaunches are interpreted optimistically.
First revenuePaid pilots lack renewal and expansion criteria.
False product-market fitPilots are counted as traction without conversion.
Stage-specific version

Adjacent Problems

  • The riskiest assumption is not identified.
  • Stated-interest signals are mistaken for commitment.
  • Willingness to pay is not validated.
  • The free pilot trap.
  • Pivot criteria are unclear.

5. Pivot, Persist, or Kill Criteria Unclear

Pre-seed and seed startups repeatedly struggle to decide whether to continue, narrow, pivot, or stop a product direction when evidence is mixed because success, failure, and ambiguity thresholds were not defined, forcing founders to extend weak directions, which leads to slow learning and runway loss.

Definition · Plain-language definition
The team does not know what evidence would make it keep going, change direction, or stop.

Why This Matters

Startups can fail slowly by continuing ambiguous bets. It recurs because founders want to preserve optionality and avoid premature conclusions. It damages product-market fit because weak evidence can persist until runway is too low to adapt. It appears from a live MVP through seed, especially after pilots, first users, first revenue, or mixed traction, and is common among technical founders, domain-expert founders, AI-native founders, research-led founders, first-time founders, and founders under investor pressure.

Root Causes

  • No pre-defined thresholds.
  • Experiments lack decision criteria.
  • Negative signals are avoided.
  • Founder identity is tied to the idea.
  • The investor narrative discourages honest reassessment.
  • Alternatives are not defined.
  • Decision deadlines are missing.

Observable Symptoms

  • Founder behavior: extends ambiguous work.
  • Product roadmap: the same bet continues despite weak evidence.
  • Customer conversations: mixed feedback is interpreted optimistically.
  • Sales calls: repeated stalls do not force change.
  • User behavior: weak usage persists.
  • Analytics: metrics are flat, but no decision is made.
  • Engineering work: continues in an uncertain direction.
  • Investor updates: language stays positive despite weak signals.
  • Team discussions: the same debate repeats.

Common Founder Language

  • “Signals are mixed.”
  • “We need more data.”
  • “Let us give it more time.”
  • “It is still early.”
  • “We are still learning.”

Diagnosis

Founders often think they need more data, more time, better analytics, more interviews, more features, or a product manager.

Consequences

  • Product direction drifts.
  • Customer learning slows.
  • UX fixes continue without clarity.
  • Retention issues are rationalized.
  • Sales keeps trying weak segments.
  • Engineering builds into uncertainty.
  • Runway burns.
  • Fundraising ability declines as milestones slip.
  • Team morale suffers from unresolved ambiguity.
Evidence test
Confirms the issueDisconfirms the issue
QualitativeNo clear pivot, persist, or kill criteria, and repeated unresolved debates.The team has clear thresholds, decision deadlines, and defined alternatives.
QuantitativeFlat or weak activation, retention, conversion, or paid commitment over time without a product or segment change.Weak evidence triggers narrowing, pivoting, stopping, or specific measurable changes.

Diagnostic Questions

  1. What evidence would make you persist?
  2. What evidence would make you pivot?
  3. What evidence would make you kill the direction?
  4. What is the decision deadline?
  5. What alternative direction is being compared?
  6. What evidence is already negative?
  7. What ambiguity remains acceptable?
  8. What assumption has not improved?
  9. Who owns the decision?
  10. What have you stopped because of evidence?
Figure 5.1
Product metricsTrend lines for activation, retention, usage, and conversion.
Customer artifactsChurn, non-use, and lost-customer notes.
Sales artifactsRepeated objections and no-decisions.
Research artifactsExperiment thresholds and decision memos.
Product artifactsPivot and narrowing plans.
Engineering artifactsContinued work on weak bets.
Metrics and artifacts to inspect
Severity

Mild

Thresholds are informal, but decisions happen.

Moderate

Weak evidence persists longer than planned.

Severe

Major product bets continue without decision logic.

Fatal

The startup delays a necessary pivot until runway is insufficient.

Figure 5.2
Pre-seedCriteria are often qualitative but should still exist.
SeedCriteria should be tied to adoption, retention, revenue, and repeatability.
Pre-MVPDecide what evidence justifies building.
Post-MVPDecide what usage or retention justifies continuation.
First revenueDecide what repeatability is required.
False product-market fitCriteria prevent overclaiming fit.
Stage-specific version

Adjacent Problems

  • Negative-signal avoidance.
  • Experiments lack decision criteria.
  • The riskiest assumption is not identified.
  • False product-market fit.
  • Sparse metrics are overinterpreted.

6. Negative-Signal Avoidance and Pivot Paralysis

Pre-seed and seed startups repeatedly struggle to act on negative evidence when churn, non-use, lost deals, weak activation, or skeptical feedback threatens the current direction because founders are attached to the idea, sunk cost, or fundraising narrative, forcing the company to rationalize weak signal, which leads to delayed pivots and wasted runway.

Definition · Plain-language definition
The team is seeing warning signs but explaining them away instead of learning from them.

Why This Matters

Startups rarely fail all at once. They often fail by ignoring weak but repeated evidence. It recurs because negative evidence is emotionally and strategically uncomfortable, and it damages product-market fit because the company keeps investing in a direction that may not be working. It appears from pre-MVP through seed, especially after MVP launch, pilots, first users, first revenue, and fundraising pressure.

Root Causes

  • Founder identity is tied to the idea.
  • Sunk cost is high.
  • Investors expect progress.
  • Negative feedback is not systematically collected.
  • Churn is not investigated.
  • Lost deals are rationalized.
  • Experiments lack kill thresholds.
  • The team lacks the psychological safety to challenge the direction.

Observable Symptoms

  • Founder behavior: explains away repeated weak signals.
  • Product roadmap: continues despite poor evidence.
  • Customer conversations: skeptics are ignored.
  • Sales calls: lost deals are blamed on timing.
  • User behavior: churn or non-use is not deeply investigated.
  • Analytics: weak metrics are reframed as early.
  • Engineering work: continues on a weak bet.
  • Investor updates: negative evidence is absent.
  • Team discussions: concerns are softened.

Common Founder Language

  • “It is still early.”
  • “Customers do not understand yet.”
  • “We need more time.”
  • “The market is not ready.”
  • “We are seeing mixed signals.”

Diagnosis

Founders often think customers need better product education, more features, better sales, more time, better onboarding, or more data.

Consequences

  • Product direction persists too long.
  • Customer learning becomes selective.
  • UX issues are rationalized.
  • Retention warnings are missed.
  • Sales repeats weak motions.
  • Engineering builds into a failing direction.
  • Runway is consumed before there is a pivot.
  • Fundraising ability weakens when reality surfaces.
  • Team morale suffers if concerns are ignored.
Evidence test
Confirms the issueDisconfirms the issue
QualitativeChurned users, skeptics, and lost customers are not interviewed, and negative feedback is absent from memos.The team actively investigates churn, non-use, lost deals, and skeptical feedback.
QuantitativePersistent weak activation, retention, conversion, or payment without a product or segment change.Negative signal leads to documented changes in ICP, product, pricing, or strategy.

Diagnostic Questions

  1. What negative evidence have you seen repeatedly?
  2. Who has stopped using the product and why?
  3. What lost-deal reasons repeat?
  4. What feedback do you disagree with?
  5. What assumption are you avoiding testing?
  6. What evidence would change your mind?
  7. What have you killed recently?
  8. What do skeptics say?
  9. What are you not telling investors?
  10. What would a fair critic say is not working?
Figure 6.1
Product metricsChurn, non-use, failed activation, weak retention.
Customer artifactsChurn interviews and non-user interviews.
Sales artifactsLost-deal analysis.
Research artifactsDisconfirmation logs.
Product artifactsPivot decisions and killed features.
Engineering artifactsContinued work despite weak evidence.
Metrics and artifacts to inspect
Severity

Mild

Negative signals are uncomfortable but investigated.

Moderate

Some weak signals are rationalized.

Severe

Repeated negative evidence does not change decisions.

Fatal

A necessary pivot is delayed until runway is gone.

Figure 6.2
Pre-seedFounders avoid evidence that weakens the idea.
SeedFounders avoid evidence that weakens the product-market fit narrative.
Pre-MVPBad discovery is explained away.
Post-MVPNon-use and churn are minimized.
First revenueWeak customer health is rationalized.
False product-market fitNegative signals are hidden under a traction narrative.
Stage-specific version

Adjacent Problems

  • Pivot criteria are unclear.
  • Experiments lack decision criteria.
  • False product-market fit.
  • Sparse metrics are overinterpreted.
  • There is a retention blind spot.

The Issues Compound

One theme you will notice with each of the six issues above is that they are often interconnected. Startups rarely fail for one single reason. They usually fail as a result of multiple reasons that compound on top of each other. Your job is to systematically remove each compounding reason.

Sylvester Mobley
Authored by

Co-Founder & CEO, Zero Vector Ventures

Sylvester is co-founder and CEO of Zero Vector Ventures, leading strategy and innovation. With over 20 years in technology and startups, he brings deep expertise in early-stage validation and the technical, design, and product challenges founders face.

Read full bio
Part of a series
Common Product Issues That Prevent Product-Market Fit
01 of 01
See the series